Clinical Trial Update: A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of revumenib in combination with chemotherapy for relapsed or refractory leukemia, with the trial currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Leukemia of Ambiguous Lineage
• Mixed Phenotype Acute Leukemia

Drugs mentioned

• Revumenib (revumenib)

Snippet

Sponsor: Children's Oncology Group | Conditions: Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING